Inhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide

Inhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide Dicarboxylic Acid Azacycle <scp>l</scp>-Prolyl-pyrrolidine Amides as Prolyl Oligopeptidase Inhibitors and Three-Dimensional Quantitative Structure−Activity Relationship of the Enzyme−Inhibitor Interactions Inhibitors of Prolyl Oligopeptidases for the Therapy of Human Diseases: Defining Diseases and Inhibitors Dicarboxylic Acidbis(<scp>l</scp>-Prolyl-pyrrolidine) Amides as Prolyl Oligopeptidase Inhibitors Synthesis of polyozellin, a prolyl oligopeptidase inhibitor, and its structural revision 3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α Inhibition of Human Prolyl Oligopeptidase Activity by the Cyclotide Psysol 2 Isolated from<i>Psychotria solitudinum</i> A Prolyl Endopeptidase-Inhibiting Benzofuran Dimer from Polyozellus multiflex